nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—systemic lupus erythematosus	0.233	1	CbGaD
Etoricoxib—PTGS2—Dapsone—systemic lupus erythematosus	0.0526	0.115	CbGbCtD
Etoricoxib—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0456	0.0995	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—systemic lupus erythematosus	0.0391	0.0853	CbGbCtD
Etoricoxib—CYP2E1—Dapsone—systemic lupus erythematosus	0.0343	0.0748	CbGbCtD
Etoricoxib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0278	0.0607	CbGbCtD
Etoricoxib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0251	0.0547	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0228	0.0496	CbGbCtD
Etoricoxib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0215	0.0469	CbGbCtD
Etoricoxib—CYP2C9—Dapsone—systemic lupus erythematosus	0.0179	0.039	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—systemic lupus erythematosus	0.0149	0.0325	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—systemic lupus erythematosus	0.0148	0.0324	CbGbCtD
Etoricoxib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0141	0.0308	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0119	0.0259	CbGbCtD
Etoricoxib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0117	0.0256	CbGbCtD
Etoricoxib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0107	0.0234	CbGbCtD
Etoricoxib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0104	0.0227	CbGbCtD
Etoricoxib—CYP2C9—cardial valve—systemic lupus erythematosus	0.00977	0.181	CbGeAlD
Etoricoxib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0093	0.0203	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00901	0.0197	CbGbCtD
Etoricoxib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00901	0.0197	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00773	0.0169	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00773	0.0169	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00763	0.0166	CbGbCtD
Etoricoxib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00723	0.0158	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—systemic lupus erythematosus	0.0072	0.0157	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00707	0.0154	CbGbCtD
Etoricoxib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00683	0.0149	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0045	0.00981	CbGbCtD
Etoricoxib—MAPK14—blood plasma—systemic lupus erythematosus	0.00334	0.0618	CbGeAlD
Etoricoxib—CYP2C19—urine—systemic lupus erythematosus	0.00272	0.0503	CbGeAlD
Etoricoxib—CYP1A2—urine—systemic lupus erythematosus	0.00222	0.0411	CbGeAlD
Etoricoxib—CYP2C9—urine—systemic lupus erythematosus	0.00211	0.039	CbGeAlD
Etoricoxib—CYP2E1—urine—systemic lupus erythematosus	0.002	0.037	CbGeAlD
Etoricoxib—MAPK14—connective tissue—systemic lupus erythematosus	0.00178	0.0329	CbGeAlD
Etoricoxib—CYP3A4—urine—systemic lupus erythematosus	0.00161	0.0298	CbGeAlD
Etoricoxib—MAPK14—skin of body—systemic lupus erythematosus	0.0016	0.0297	CbGeAlD
Etoricoxib—CYP2D6—urine—systemic lupus erythematosus	0.00158	0.0293	CbGeAlD
Etoricoxib—MAPK14—kidney—systemic lupus erythematosus	0.00151	0.028	CbGeAlD
Etoricoxib—CYP2C19—blood plasma—systemic lupus erythematosus	0.00142	0.0263	CbGeAlD
Etoricoxib—MAPK14—lymphoid tissue—systemic lupus erythematosus	0.0013	0.0241	CbGeAlD
Etoricoxib—MAPK14—tendon—systemic lupus erythematosus	0.00122	0.0226	CbGeAlD
Etoricoxib—MAPK14—bone marrow—systemic lupus erythematosus	0.00118	0.0219	CbGeAlD
Etoricoxib—CYP1A2—blood plasma—systemic lupus erythematosus	0.00116	0.0215	CbGeAlD
Etoricoxib—CYP2C9—blood plasma—systemic lupus erythematosus	0.0011	0.0204	CbGeAlD
Etoricoxib—PTGS2—endothelium—systemic lupus erythematosus	0.00108	0.02	CbGeAlD
Etoricoxib—MAPK14—lung—systemic lupus erythematosus	0.00107	0.0198	CbGeAlD
Etoricoxib—CYP2E1—blood plasma—systemic lupus erythematosus	0.00104	0.0193	CbGeAlD
Etoricoxib—MAPK14—nervous system—systemic lupus erythematosus	0.000993	0.0184	CbGeAlD
Etoricoxib—PTGS2—blood plasma—systemic lupus erythematosus	0.00096	0.0178	CbGeAlD
Etoricoxib—MAPK14—central nervous system—systemic lupus erythematosus	0.000956	0.0177	CbGeAlD
Etoricoxib—Vemurafenib—ALB—systemic lupus erythematosus	0.000944	0.364	CrCbGaD
Etoricoxib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000839	0.0155	CbGeAlD
Etoricoxib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000825	0.0153	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—systemic lupus erythematosus	0.000623	0.24	CrCbGaD
Etoricoxib—Celecoxib—ALB—systemic lupus erythematosus	0.000555	0.214	CrCbGaD
Etoricoxib—CYP2E1—nephron tubule—systemic lupus erythematosus	0.000538	0.00995	CbGeAlD
Etoricoxib—PTGS2—connective tissue—systemic lupus erythematosus	0.000511	0.00946	CbGeAlD
Etoricoxib—Vismodegib—ALB—systemic lupus erythematosus	0.000476	0.183	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000473	0.159	CbGdCrCtD
Etoricoxib—CYP2E1—kidney—systemic lupus erythematosus	0.000473	0.00875	CbGeAlD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000465	0.156	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000465	0.156	CbGdCrCtD
Etoricoxib—PTGS2—skin of body—systemic lupus erythematosus	0.000461	0.00854	CbGeAlD
Etoricoxib—CYP2E1—cortex of kidney—systemic lupus erythematosus	0.00046	0.00852	CbGeAlD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000454	0.153	CbGdCrCtD
Etoricoxib—PTGS2—kidney—systemic lupus erythematosus	0.000435	0.00805	CbGeAlD
Etoricoxib—CYP2E1—lymphoid tissue—systemic lupus erythematosus	0.000406	0.00751	CbGeAlD
Etoricoxib—CYP2E1—tendon—systemic lupus erythematosus	0.000382	0.00706	CbGeAlD
Etoricoxib—CYP3A4—kidney—systemic lupus erythematosus	0.00038	0.00704	CbGeAlD
Etoricoxib—CYP2D6—kidney—systemic lupus erythematosus	0.000374	0.00692	CbGeAlD
Etoricoxib—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000374	0.00692	CbGeAlD
Etoricoxib—CYP1A2—lung—systemic lupus erythematosus	0.000372	0.00689	CbGeAlD
Etoricoxib—PTGS2—tendon—systemic lupus erythematosus	0.000351	0.0065	CbGeAlD
Etoricoxib—PTGS2—bone marrow—systemic lupus erythematosus	0.00034	0.0063	CbGeAlD
Etoricoxib—CYP2E1—lung—systemic lupus erythematosus	0.000335	0.0062	CbGeAlD
Etoricoxib—CYP2E1—nervous system—systemic lupus erythematosus	0.00031	0.00574	CbGeAlD
Etoricoxib—PTGS2—lung—systemic lupus erythematosus	0.000308	0.00571	CbGeAlD
Etoricoxib—CYP2E1—central nervous system—systemic lupus erythematosus	0.000298	0.00552	CbGeAlD
Etoricoxib—PTGS2—nervous system—systemic lupus erythematosus	0.000285	0.00528	CbGeAlD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000285	0.0958	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000281	0.0942	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000281	0.0942	CbGdCrCtD
Etoricoxib—PTGS2—central nervous system—systemic lupus erythematosus	0.000275	0.00509	CbGeAlD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000274	0.0921	CbGdCrCtD
Etoricoxib—CYP3A4—nervous system—systemic lupus erythematosus	0.000249	0.00462	CbGeAlD
Etoricoxib—CYP2D6—nervous system—systemic lupus erythematosus	0.000245	0.00454	CbGeAlD
Etoricoxib—CYP3A4—central nervous system—systemic lupus erythematosus	0.00024	0.00445	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—systemic lupus erythematosus	0.000236	0.00437	CbGeAlD
Etoricoxib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	8.01e-05	0.000498	CcSEcCtD
Etoricoxib—Epistaxis—Methotrexate—systemic lupus erythematosus	8e-05	0.000497	CcSEcCtD
Etoricoxib—Rash—Leflunomide—systemic lupus erythematosus	8e-05	0.000497	CcSEcCtD
Etoricoxib—Dermatitis—Leflunomide—systemic lupus erythematosus	7.99e-05	0.000497	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—systemic lupus erythematosus	7.98e-05	0.000496	CcSEcCtD
Etoricoxib—Nausea—Azathioprine—systemic lupus erythematosus	7.98e-05	0.000496	CcSEcCtD
Etoricoxib—Headache—Leflunomide—systemic lupus erythematosus	7.95e-05	0.000494	CcSEcCtD
Etoricoxib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	7.94e-05	0.000494	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—systemic lupus erythematosus	7.93e-05	0.000493	CcSEcCtD
Etoricoxib—Erythema—Prednisone—systemic lupus erythematosus	7.93e-05	0.000493	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	7.93e-05	0.000493	CcSEcCtD
Etoricoxib—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	7.87e-05	0.000489	CcSEcCtD
Etoricoxib—Insomnia—Hydrocortisone—systemic lupus erythematosus	7.87e-05	0.000489	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—systemic lupus erythematosus	7.86e-05	0.000489	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—systemic lupus erythematosus	7.86e-05	0.000489	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	7.81e-05	0.000485	CcSEcCtD
Etoricoxib—Urticaria—Cyclosporine—systemic lupus erythematosus	7.78e-05	0.000483	CcSEcCtD
Etoricoxib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	7.74e-05	0.000481	CcSEcCtD
Etoricoxib—Anxiety—Dexamethasone—systemic lupus erythematosus	7.73e-05	0.00048	CcSEcCtD
Etoricoxib—Anxiety—Betamethasone—systemic lupus erythematosus	7.73e-05	0.00048	CcSEcCtD
Etoricoxib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	7.66e-05	0.000476	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—systemic lupus erythematosus	7.65e-05	0.000476	CcSEcCtD
Etoricoxib—Pain—Prednisolone—systemic lupus erythematosus	7.62e-05	0.000474	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000473	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000473	CcSEcCtD
Etoricoxib—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.59e-05	0.000472	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	7.56e-05	0.00047	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—systemic lupus erythematosus	7.56e-05	0.00047	CcSEcCtD
Etoricoxib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	7.55e-05	0.000469	CcSEcCtD
Etoricoxib—Nausea—Leflunomide—systemic lupus erythematosus	7.54e-05	0.000468	CcSEcCtD
Etoricoxib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	7.52e-05	0.000467	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	7.51e-05	0.000467	CcSEcCtD
Etoricoxib—Fatigue—Hydrocortisone—systemic lupus erythematosus	7.5e-05	0.000466	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—systemic lupus erythematosus	7.48e-05	0.000465	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—systemic lupus erythematosus	7.47e-05	0.000464	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	7.46e-05	0.000464	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	7.45e-05	0.000463	CcSEcCtD
Etoricoxib—Pain—Hydrocortisone—systemic lupus erythematosus	7.44e-05	0.000462	CcSEcCtD
Etoricoxib—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.43e-05	0.000462	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.43e-05	0.000462	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—systemic lupus erythematosus	7.43e-05	0.000462	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—systemic lupus erythematosus	7.43e-05	0.000462	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—systemic lupus erythematosus	7.41e-05	0.000461	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—systemic lupus erythematosus	7.39e-05	0.00046	CcSEcCtD
Etoricoxib—Infection—Betamethasone—systemic lupus erythematosus	7.39e-05	0.000459	CcSEcCtD
Etoricoxib—Infection—Dexamethasone—systemic lupus erythematosus	7.39e-05	0.000459	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.34e-05	0.000456	CcSEcCtD
Etoricoxib—Visual impairment—Methotrexate—systemic lupus erythematosus	7.34e-05	0.000456	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—systemic lupus erythematosus	7.33e-05	0.000456	CcSEcCtD
Etoricoxib—Shock—Betamethasone—systemic lupus erythematosus	7.31e-05	0.000455	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—systemic lupus erythematosus	7.31e-05	0.000455	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.3e-05	0.000454	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	7.29e-05	0.000453	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	7.29e-05	0.000453	CcSEcCtD
Etoricoxib—Agitation—Prednisone—systemic lupus erythematosus	7.29e-05	0.000453	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	7.28e-05	0.000452	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	7.28e-05	0.000452	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—systemic lupus erythematosus	7.25e-05	0.00045	CcSEcCtD
Etoricoxib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.21e-05	0.000448	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	7.21e-05	0.000448	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	7.2e-05	0.000448	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	7.2e-05	0.000447	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	7.17e-05	0.000446	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—systemic lupus erythematosus	7.12e-05	0.000442	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	7.12e-05	0.000442	CcSEcCtD
Etoricoxib—Tinnitus—Methotrexate—systemic lupus erythematosus	7.1e-05	0.000441	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—systemic lupus erythematosus	7.09e-05	0.00044	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—systemic lupus erythematosus	7.09e-05	0.00044	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—systemic lupus erythematosus	7.08e-05	0.00044	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	7.07e-05	0.000439	CcSEcCtD
Etoricoxib—Fatigue—Triamcinolone—systemic lupus erythematosus	7.06e-05	0.000439	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—systemic lupus erythematosus	7.05e-05	0.000438	CcSEcCtD
Etoricoxib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	7.04e-05	0.000437	CcSEcCtD
Etoricoxib—Asthenia—Cyclosporine—systemic lupus erythematosus	7.02e-05	0.000437	CcSEcCtD
Etoricoxib—Pain—Triamcinolone—systemic lupus erythematosus	7.01e-05	0.000435	CcSEcCtD
Etoricoxib—Pruritus—Cyclosporine—systemic lupus erythematosus	6.93e-05	0.000431	CcSEcCtD
Etoricoxib—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.91e-05	0.00043	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—systemic lupus erythematosus	6.91e-05	0.000429	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000428	CcSEcCtD
Etoricoxib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	6.88e-05	0.000428	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	6.86e-05	0.000427	CcSEcCtD
Etoricoxib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.85e-05	0.000426	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—systemic lupus erythematosus	6.85e-05	0.000426	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	6.77e-05	0.000421	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	6.77e-05	0.000421	CcSEcCtD
Etoricoxib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.76e-05	0.00042	CcSEcCtD
Etoricoxib—Arthralgia—Prednisone—systemic lupus erythematosus	6.75e-05	0.00042	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.75e-05	0.00042	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.74e-05	0.000419	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—systemic lupus erythematosus	6.73e-05	0.000418	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—systemic lupus erythematosus	6.73e-05	0.000418	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—systemic lupus erythematosus	6.72e-05	0.000418	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—systemic lupus erythematosus	6.72e-05	0.000418	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.71e-05	0.000417	CcSEcCtD
Etoricoxib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.7e-05	0.000416	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.68e-05	0.000415	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—systemic lupus erythematosus	6.67e-05	0.000415	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—systemic lupus erythematosus	6.63e-05	0.000412	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—systemic lupus erythematosus	6.63e-05	0.000412	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.56e-05	0.000408	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—systemic lupus erythematosus	6.54e-05	0.000407	CcSEcCtD
Etoricoxib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	6.54e-05	0.000407	CcSEcCtD
Etoricoxib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.54e-05	0.000406	CcSEcCtD
Etoricoxib—Urticaria—Triamcinolone—systemic lupus erythematosus	6.51e-05	0.000405	CcSEcCtD
Etoricoxib—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.49e-05	0.000404	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—systemic lupus erythematosus	6.49e-05	0.000403	CcSEcCtD
Etoricoxib—Dizziness—Cyclosporine—systemic lupus erythematosus	6.47e-05	0.000402	CcSEcCtD
Etoricoxib—Oedema—Prednisone—systemic lupus erythematosus	6.47e-05	0.000402	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.47e-05	0.000402	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	6.46e-05	0.000402	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	6.46e-05	0.000402	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—systemic lupus erythematosus	6.46e-05	0.000402	CcSEcCtD
Etoricoxib—Infection—Prednisone—systemic lupus erythematosus	6.43e-05	0.0004	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	6.42e-05	0.000399	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	6.42e-05	0.000399	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.41e-05	0.000398	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000398	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000398	CcSEcCtD
Etoricoxib—Shock—Prednisone—systemic lupus erythematosus	6.37e-05	0.000396	CcSEcCtD
Etoricoxib—Pain—Betamethasone—systemic lupus erythematosus	6.36e-05	0.000395	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—systemic lupus erythematosus	6.36e-05	0.000395	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—systemic lupus erythematosus	6.35e-05	0.000395	CcSEcCtD
Etoricoxib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.32e-05	0.000393	CcSEcCtD
Etoricoxib—Skin disorder—Prednisone—systemic lupus erythematosus	6.29e-05	0.000391	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—systemic lupus erythematosus	6.25e-05	0.000388	CcSEcCtD
Etoricoxib—Asthenia—Hydrocortisone—systemic lupus erythematosus	6.24e-05	0.000388	CcSEcCtD
Etoricoxib—Vomiting—Cyclosporine—systemic lupus erythematosus	6.23e-05	0.000387	CcSEcCtD
Etoricoxib—Rash—Cyclosporine—systemic lupus erythematosus	6.17e-05	0.000384	CcSEcCtD
Etoricoxib—Anorexia—Prednisone—systemic lupus erythematosus	6.17e-05	0.000384	CcSEcCtD
Etoricoxib—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.17e-05	0.000383	CcSEcCtD
Etoricoxib—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.16e-05	0.000383	CcSEcCtD
Etoricoxib—Headache—Cyclosporine—systemic lupus erythematosus	6.13e-05	0.000381	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—systemic lupus erythematosus	6.13e-05	0.000381	CcSEcCtD
Etoricoxib—Feeling abnormal—Betamethasone—systemic lupus erythematosus	6.13e-05	0.000381	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	6.13e-05	0.000381	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	6.08e-05	0.000378	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	6.08e-05	0.000378	CcSEcCtD
Etoricoxib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	6.07e-05	0.000377	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	6.04e-05	0.000375	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	6.02e-05	0.000374	CcSEcCtD
Etoricoxib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.02e-05	0.000374	CcSEcCtD
Etoricoxib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.02e-05	0.000374	CcSEcCtD
Etoricoxib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.98e-05	0.000372	CcSEcCtD
Etoricoxib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.95e-05	0.00037	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—systemic lupus erythematosus	5.91e-05	0.000367	CcSEcCtD
Etoricoxib—Urticaria—Betamethasone—systemic lupus erythematosus	5.91e-05	0.000367	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.9e-05	0.000367	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—systemic lupus erythematosus	5.89e-05	0.000366	CcSEcCtD
Etoricoxib—Asthenia—Triamcinolone—systemic lupus erythematosus	5.88e-05	0.000365	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.88e-05	0.000365	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.88e-05	0.000365	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.87e-05	0.000365	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—systemic lupus erythematosus	5.86e-05	0.000364	CcSEcCtD
Etoricoxib—Nausea—Cyclosporine—systemic lupus erythematosus	5.82e-05	0.000361	CcSEcCtD
Etoricoxib—Pruritus—Triamcinolone—systemic lupus erythematosus	5.8e-05	0.00036	CcSEcCtD
Etoricoxib—Cough—Methotrexate—systemic lupus erythematosus	5.79e-05	0.00036	CcSEcCtD
Etoricoxib—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.78e-05	0.000359	CcSEcCtD
Etoricoxib—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.75e-05	0.000358	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—systemic lupus erythematosus	5.7e-05	0.000354	CcSEcCtD
Etoricoxib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.67e-05	0.000353	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000351	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000351	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—systemic lupus erythematosus	5.63e-05	0.00035	CcSEcCtD
Etoricoxib—Rash—Prednisolone—systemic lupus erythematosus	5.62e-05	0.000349	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—systemic lupus erythematosus	5.61e-05	0.000349	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.61e-05	0.000348	CcSEcCtD
Etoricoxib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.59e-05	0.000348	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—systemic lupus erythematosus	5.58e-05	0.000347	CcSEcCtD
Etoricoxib—Headache—Prednisolone—systemic lupus erythematosus	5.58e-05	0.000347	CcSEcCtD
Etoricoxib—Constipation—Prednisone—systemic lupus erythematosus	5.54e-05	0.000344	CcSEcCtD
Etoricoxib—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.53e-05	0.000344	CcSEcCtD
Etoricoxib—Rash—Hydrocortisone—systemic lupus erythematosus	5.49e-05	0.000341	CcSEcCtD
Etoricoxib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.48e-05	0.000341	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—systemic lupus erythematosus	5.46e-05	0.000339	CcSEcCtD
Etoricoxib—Headache—Hydrocortisone—systemic lupus erythematosus	5.45e-05	0.000339	CcSEcCtD
Etoricoxib—Dizziness—Triamcinolone—systemic lupus erythematosus	5.42e-05	0.000337	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.41e-05	0.000336	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.41e-05	0.000336	CcSEcCtD
Etoricoxib—Infection—Methotrexate—systemic lupus erythematosus	5.38e-05	0.000334	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.34e-05	0.000332	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—systemic lupus erythematosus	5.33e-05	0.000332	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—systemic lupus erythematosus	5.33e-05	0.000332	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.31e-05	0.00033	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.3e-05	0.000329	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	5.29e-05	0.000329	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—systemic lupus erythematosus	5.29e-05	0.000329	CcSEcCtD
Etoricoxib—Pruritus—Betamethasone—systemic lupus erythematosus	5.26e-05	0.000327	CcSEcCtD
Etoricoxib—Pruritus—Dexamethasone—systemic lupus erythematosus	5.26e-05	0.000327	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—systemic lupus erythematosus	5.26e-05	0.000327	CcSEcCtD
Etoricoxib—Vomiting—Triamcinolone—systemic lupus erythematosus	5.21e-05	0.000324	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.2e-05	0.000323	CcSEcCtD
Etoricoxib—Nausea—Hydrocortisone—systemic lupus erythematosus	5.17e-05	0.000321	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—systemic lupus erythematosus	5.17e-05	0.000321	CcSEcCtD
Etoricoxib—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.16e-05	0.000321	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—systemic lupus erythematosus	5.16e-05	0.000321	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—systemic lupus erythematosus	5.15e-05	0.00032	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.15e-05	0.00032	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—systemic lupus erythematosus	5.14e-05	0.00032	CcSEcCtD
Etoricoxib—Headache—Triamcinolone—systemic lupus erythematosus	5.13e-05	0.000319	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—systemic lupus erythematosus	5.12e-05	0.000318	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—systemic lupus erythematosus	5.12e-05	0.000318	CcSEcCtD
Etoricoxib—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.09e-05	0.000316	CcSEcCtD
Etoricoxib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.09e-05	0.000316	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.93e-05	0.000306	CcSEcCtD
Etoricoxib—Dizziness—Betamethasone—systemic lupus erythematosus	4.92e-05	0.000306	CcSEcCtD
Etoricoxib—Dizziness—Dexamethasone—systemic lupus erythematosus	4.92e-05	0.000306	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000304	CcSEcCtD
Etoricoxib—Nausea—Triamcinolone—systemic lupus erythematosus	4.87e-05	0.000302	CcSEcCtD
Etoricoxib—Nausea—Methylprednisolone—systemic lupus erythematosus	4.86e-05	0.000302	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.82e-05	0.0003	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000299	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.77e-05	0.000296	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.76e-05	0.000296	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—systemic lupus erythematosus	4.73e-05	0.000294	CcSEcCtD
Etoricoxib—Vomiting—Betamethasone—systemic lupus erythematosus	4.73e-05	0.000294	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000292	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—systemic lupus erythematosus	4.69e-05	0.000291	CcSEcCtD
Etoricoxib—Rash—Betamethasone—systemic lupus erythematosus	4.69e-05	0.000291	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.68e-05	0.000291	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—systemic lupus erythematosus	4.68e-05	0.000291	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.67e-05	0.00029	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—systemic lupus erythematosus	4.66e-05	0.00029	CcSEcCtD
Etoricoxib—Headache—Betamethasone—systemic lupus erythematosus	4.66e-05	0.000289	CcSEcCtD
Etoricoxib—Headache—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.000289	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—systemic lupus erythematosus	4.65e-05	0.000289	CcSEcCtD
Etoricoxib—Pain—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000288	CcSEcCtD
Etoricoxib—Pruritus—Prednisone—systemic lupus erythematosus	4.58e-05	0.000285	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.46e-05	0.000277	CcSEcCtD
Etoricoxib—Diarrhoea—Prednisone—systemic lupus erythematosus	4.43e-05	0.000275	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.42e-05	0.000275	CcSEcCtD
Etoricoxib—Nausea—Dexamethasone—systemic lupus erythematosus	4.42e-05	0.000274	CcSEcCtD
Etoricoxib—Nausea—Betamethasone—systemic lupus erythematosus	4.42e-05	0.000274	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—systemic lupus erythematosus	4.3e-05	0.000267	CcSEcCtD
Etoricoxib—Dizziness—Prednisone—systemic lupus erythematosus	4.28e-05	0.000266	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000266	CcSEcCtD
Etoricoxib—Vomiting—Prednisone—systemic lupus erythematosus	4.12e-05	0.000256	CcSEcCtD
Etoricoxib—Rash—Prednisone—systemic lupus erythematosus	4.08e-05	0.000254	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—systemic lupus erythematosus	4.08e-05	0.000253	CcSEcCtD
Etoricoxib—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	4.07e-05	0.000461	CbGpPWpGaD
Etoricoxib—Headache—Prednisone—systemic lupus erythematosus	4.06e-05	0.000252	CcSEcCtD
Etoricoxib—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4.03e-05	0.000457	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IFNA1—systemic lupus erythematosus	4.03e-05	0.000456	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—systemic lupus erythematosus	4.01e-05	0.000454	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.99e-05	0.000248	CcSEcCtD
Etoricoxib—MAPK14—Immune System—FCGR3A—systemic lupus erythematosus	3.94e-05	0.000446	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RASGRP1—systemic lupus erythematosus	3.92e-05	0.000444	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	3.92e-05	0.000444	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RIPK1—systemic lupus erythematosus	3.89e-05	0.000441	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN1A—systemic lupus erythematosus	3.89e-05	0.00044	CbGpPWpGaD
Etoricoxib—Asthenia—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000241	CcSEcCtD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—CDKN1B—systemic lupus erythematosus	3.88e-05	0.00044	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	3.87e-05	0.000439	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.87e-05	0.000439	CbGpPWpGaD
Etoricoxib—Nausea—Prednisone—systemic lupus erythematosus	3.85e-05	0.000239	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—systemic lupus erythematosus	3.83e-05	0.000238	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—systemic lupus erythematosus	3.83e-05	0.000434	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.8e-05	0.000431	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	3.79e-05	0.000429	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	3.79e-05	0.000429	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—systemic lupus erythematosus	3.77e-05	0.000427	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR9—systemic lupus erythematosus	3.76e-05	0.000426	CbGpPWpGaD
Etoricoxib—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.7e-05	0.00023	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.62e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—systemic lupus erythematosus	3.61e-05	0.000409	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	3.59e-05	0.000407	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	3.58e-05	0.000406	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—CDKN1A—systemic lupus erythematosus	3.58e-05	0.000406	CbGpPWpGaD
Etoricoxib—Dizziness—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000222	CcSEcCtD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—systemic lupus erythematosus	3.56e-05	0.000403	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.55e-05	0.000402	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—TYK2—systemic lupus erythematosus	3.51e-05	0.000398	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.49e-05	0.000395	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—systemic lupus erythematosus	3.49e-05	0.000395	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—JAK1—systemic lupus erythematosus	3.44e-05	0.00039	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	3.44e-05	0.00039	CbGpPWpGaD
Etoricoxib—Vomiting—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000214	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.43e-05	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.42e-05	0.000387	CbGpPWpGaD
Etoricoxib—Rash—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000212	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000212	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—systemic lupus erythematosus	3.39e-05	0.000384	CbGpPWpGaD
Etoricoxib—Headache—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000211	CcSEcCtD
Etoricoxib—MAPK14—Hemostasis—JAK1—systemic lupus erythematosus	3.38e-05	0.000383	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CSK—systemic lupus erythematosus	3.35e-05	0.00038	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MBL2—systemic lupus erythematosus	3.32e-05	0.000376	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.32e-05	0.000376	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	3.32e-05	0.000376	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRF5—systemic lupus erythematosus	3.3e-05	0.000373	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—systemic lupus erythematosus	3.26e-05	0.000369	CbGpPWpGaD
Etoricoxib—Nausea—Methotrexate—systemic lupus erythematosus	3.21e-05	0.0002	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	3.18e-05	0.00036	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2RA—systemic lupus erythematosus	3.16e-05	0.000358	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRF8—systemic lupus erythematosus	3.15e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFIH1—systemic lupus erythematosus	3.15e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD247—systemic lupus erythematosus	3.15e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ITGAM—systemic lupus erythematosus	3.15e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.15e-05	0.000356	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NCF2—systemic lupus erythematosus	3.06e-05	0.000347	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	3.06e-05	0.000346	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	3.05e-05	0.000346	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—LYN—systemic lupus erythematosus	3.04e-05	0.000345	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—JAK1—systemic lupus erythematosus	3.04e-05	0.000345	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	3.02e-05	0.000342	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FCGR2A—systemic lupus erythematosus	3e-05	0.00034	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—CDKN1B—systemic lupus erythematosus	2.98e-05	0.000338	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	2.95e-05	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TNFAIP3—systemic lupus erythematosus	2.95e-05	0.000334	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.94e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	2.94e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BLK—systemic lupus erythematosus	2.91e-05	0.00033	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—C3—systemic lupus erythematosus	2.82e-05	0.000319	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.82e-05	0.000319	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	2.8e-05	0.000317	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—EP300—systemic lupus erythematosus	2.79e-05	0.000317	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	2.76e-05	0.000313	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—CDKN1A—systemic lupus erythematosus	2.75e-05	0.000312	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—XRCC6—systemic lupus erythematosus	2.75e-05	0.000312	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—F2—systemic lupus erythematosus	2.75e-05	0.000311	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—systemic lupus erythematosus	2.68e-05	0.000304	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.66e-05	0.000301	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—VEGFA—systemic lupus erythematosus	2.65e-05	0.0003	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.63e-05	0.000298	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTPRC—systemic lupus erythematosus	2.61e-05	0.000295	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1RN—systemic lupus erythematosus	2.59e-05	0.000294	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PPARG—systemic lupus erythematosus	2.59e-05	0.000293	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—systemic lupus erythematosus	2.57e-05	0.000291	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TLR9—systemic lupus erythematosus	2.43e-05	0.000275	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.43e-05	0.000275	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40—systemic lupus erythematosus	2.42e-05	0.000274	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—systemic lupus erythematosus	2.42e-05	0.000274	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—JUNB—systemic lupus erythematosus	2.39e-05	0.000271	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTLA4—systemic lupus erythematosus	2.39e-05	0.00027	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HMGB1—systemic lupus erythematosus	2.39e-05	0.00027	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD80—systemic lupus erythematosus	2.37e-05	0.000269	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.35e-05	0.000267	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNA1—systemic lupus erythematosus	2.35e-05	0.000266	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.34e-05	0.000265	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.31e-05	0.000262	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RASGRP1—systemic lupus erythematosus	2.28e-05	0.000259	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—systemic lupus erythematosus	2.28e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD79A—systemic lupus erythematosus	2.28e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TYK2—systemic lupus erythematosus	2.27e-05	0.000257	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	2.23e-05	0.000253	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.23e-05	0.000252	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.22e-05	0.000252	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PRL—systemic lupus erythematosus	2.22e-05	0.000251	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.19e-05	0.000248	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS3—systemic lupus erythematosus	2.18e-05	0.000247	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CSK—systemic lupus erythematosus	2.17e-05	0.000245	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQA1—systemic lupus erythematosus	2.1e-05	0.000238	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—RXRA—systemic lupus erythematosus	2.1e-05	0.000237	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	2.03e-05	0.00023	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.01e-05	0.000228	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TYK2—systemic lupus erythematosus	2e-05	0.000227	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NCF2—systemic lupus erythematosus	1.98e-05	0.000224	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CSK—systemic lupus erythematosus	1.98e-05	0.000224	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LYN—systemic lupus erythematosus	1.97e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—systemic lupus erythematosus	1.97e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.93e-05	0.000219	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—systemic lupus erythematosus	1.9e-05	0.000215	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.88e-05	0.000213	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—systemic lupus erythematosus	1.86e-05	0.000211	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD247—systemic lupus erythematosus	1.86e-05	0.000211	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.86e-05	0.00021	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—systemic lupus erythematosus	1.86e-05	0.00021	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—systemic lupus erythematosus	1.85e-05	0.00021	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—systemic lupus erythematosus	1.84e-05	0.000208	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—systemic lupus erythematosus	1.83e-05	0.000207	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—systemic lupus erythematosus	1.81e-05	0.000205	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.81e-05	0.000205	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—systemic lupus erythematosus	1.78e-05	0.000202	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JAK1—systemic lupus erythematosus	1.77e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NAT2—systemic lupus erythematosus	1.75e-05	0.000198	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—systemic lupus erythematosus	1.72e-05	0.000194	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR3C1—systemic lupus erythematosus	1.71e-05	0.000194	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.7e-05	0.000193	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.7e-05	0.000192	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EP300—systemic lupus erythematosus	1.69e-05	0.000192	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—EP300—systemic lupus erythematosus	1.66e-05	0.000188	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2RA—systemic lupus erythematosus	1.65e-05	0.000187	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—C3—systemic lupus erythematosus	1.64e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—systemic lupus erythematosus	1.6e-05	0.000182	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.58e-05	0.000179	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—systemic lupus erythematosus	1.57e-05	0.000178	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.57e-05	0.000178	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—systemic lupus erythematosus	1.56e-05	0.000177	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUNB—systemic lupus erythematosus	1.55e-05	0.000176	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.55e-05	0.000175	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—systemic lupus erythematosus	1.5e-05	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—systemic lupus erythematosus	1.49e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EP300—systemic lupus erythematosus	1.49e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.48e-05	0.000167	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.48e-05	0.000167	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—systemic lupus erythematosus	1.47e-05	0.000167	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—systemic lupus erythematosus	1.44e-05	0.000164	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRL—systemic lupus erythematosus	1.43e-05	0.000162	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JUNB—systemic lupus erythematosus	1.42e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD80—systemic lupus erythematosus	1.38e-05	0.000156	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—systemic lupus erythematosus	1.37e-05	0.000156	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.35e-05	0.000153	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.33e-05	0.00015	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—systemic lupus erythematosus	1.32e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.32e-05	0.00015	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRL—systemic lupus erythematosus	1.31e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.24e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.23e-05	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TYK2—systemic lupus erythematosus	1.17e-05	0.000132	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JAK1—systemic lupus erythematosus	1.15e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—systemic lupus erythematosus	1.11e-05	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—systemic lupus erythematosus	1.09e-05	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—systemic lupus erythematosus	1.09e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.07e-05	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.07e-05	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—C3—systemic lupus erythematosus	1.06e-05	0.00012	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—systemic lupus erythematosus	1.05e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.05e-05	0.000119	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JAK1—systemic lupus erythematosus	1.05e-05	0.000118	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	1.04e-05	0.000118	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1B—systemic lupus erythematosus	9.91e-06	0.000112	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—systemic lupus erythematosus	9.9e-06	0.000112	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RXRA—systemic lupus erythematosus	9.8e-06	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—systemic lupus erythematosus	9.79e-06	0.000111	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.77e-06	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—systemic lupus erythematosus	9.7e-06	0.00011	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.65e-06	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.64e-06	0.000109	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—F2—systemic lupus erythematosus	9.31e-06	0.000106	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1A—systemic lupus erythematosus	9.15e-06	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD80—systemic lupus erythematosus	8.93e-06	0.000101	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.79e-06	9.96e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EP300—systemic lupus erythematosus	8.7e-06	9.86e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.43e-06	9.55e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.35e-06	9.46e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—systemic lupus erythematosus	8.3e-06	9.4e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD80—systemic lupus erythematosus	8.15e-06	9.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	8.11e-06	9.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.69e-06	8.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	7.56e-06	8.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TYK2—systemic lupus erythematosus	7.54e-06	8.54e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.51e-06	8.51e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—systemic lupus erythematosus	7.4e-06	8.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.01e-06	7.94e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	6.95e-06	7.88e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	6.89e-06	7.81e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TYK2—systemic lupus erythematosus	6.88e-06	7.79e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—systemic lupus erythematosus	6.75e-06	7.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	6.57e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.57e-06	7.44e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.41e-06	7.26e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.39e-06	7.24e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—systemic lupus erythematosus	6.27e-06	7.11e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—systemic lupus erythematosus	6.22e-06	7.05e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—systemic lupus erythematosus	6.19e-06	7.01e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—systemic lupus erythematosus	5.94e-06	6.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.91e-06	6.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—systemic lupus erythematosus	5.91e-06	6.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.89e-06	6.67e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	5.85e-06	6.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—systemic lupus erythematosus	5.7e-06	6.46e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	5.65e-06	6.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EP300—systemic lupus erythematosus	5.63e-06	6.38e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—systemic lupus erythematosus	5.56e-06	6.3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.46e-06	6.19e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	5.4e-06	6.11e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.33e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—systemic lupus erythematosus	5.32e-06	6.03e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EP300—systemic lupus erythematosus	5.13e-06	5.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.89e-06	5.54e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—systemic lupus erythematosus	4.87e-06	5.51e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	4.77e-06	5.41e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.55e-06	5.15e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—systemic lupus erythematosus	4.46e-06	5.06e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	4.39e-06	4.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	4.35e-06	4.93e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—EP300—systemic lupus erythematosus	4.3e-06	4.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	4.29e-06	4.86e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	4.11e-06	4.65e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—EP300—systemic lupus erythematosus	4.05e-06	4.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.95e-06	4.47e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.91e-06	4.43e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.78e-06	4.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	3.75e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.74e-06	4.24e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.72e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—systemic lupus erythematosus	3.69e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	3.45e-06	3.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.42e-06	3.88e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—systemic lupus erythematosus	3.36e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	3.34e-06	3.79e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	3.2e-06	3.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	3.12e-06	3.54e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.93e-06	3.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.87e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.87e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.85e-06	3.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.58e-06	2.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.47e-06	2.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.43e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.26e-06	2.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.88e-06	2.13e-05	CbGpPWpGaD
